Invesco Dynamic Biotechnology & Gen... (PBE)

$65.3

-1.26 (-1.89%)
Rating:
Recommendation:
-
Symbol PBE
Price $65.3
Beta 0.000
Volume Avg. 0.01M
Market Cap 297.115M
Shares () -
52 Week Range 51.39-79.92
1y Target Est -
DCF Unlevered PBE DCF ->
DCF Levered PBE LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E 2.89 Buy
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


None
New York Stock Exchange Arca

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.